Harliku (nitisinone): first FDA-approved disease-modifying therapy for alkaptonuria. [PDF]
Chandani HK +4 more
europepmc +1 more source
A Rare Diagnosis in a Resource-Limited Setting: Alkaptonuria in a Young Dominican Child. [PDF]
Ortiz Hernández IY +4 more
europepmc +1 more source
Intraoperative Findings in Total Hip Arthroplasty Leading to a Diagnosis of Alkaptonuria in a Patient With Severe Hip Osteoarthritis Initially Attributed to Rheumatoid Arthritis: A Case Report. [PDF]
Tzellios IK +3 more
europepmc +1 more source
Evaluation of Patients Diagnosed with Inherited Metabolic Diseases in Adulthood. [PDF]
Gulten ZA +3 more
europepmc +1 more source
Treatment of Ochronotic Osteoarthropathy and the Evaluation of Selected Lower Limb Muscle Properties, Including the Patellar Tendon: A Case Report and Mini Literature Review. [PDF]
Jarecki J +11 more
europepmc +1 more source
The First 40 Years of Molecular Ophthalmology Part Two: Diseases of the Primary Cilium and Heritable Glaucoma: The 2026 Friedenwald Lecture. [PDF]
Sheffield VC.
europepmc +1 more source
Clinical and molecular characteristics of Chinese patients with alkaptonuria: 4-year follow-up of a pediatric patient and literature review. [PDF]
Qiu X +9 more
europepmc +1 more source
Incidental Discovery of Ochronosis During Total Knee Arthroplasty: A Case Report and Literature Review. [PDF]
Demain A, Willemart E.
europepmc +1 more source

